Is routine ophthalmoscopy really necessary in candidemic patients?

• DOI: 10.1371/journal.pone.0183485
• Publication Date: 2017-10-24T18:00:46Z
• Authors: Antonio Vena; Patricia Muñoz; Belen Padilla; Maricela Valerio; Maria Isabel Sanchez; Mireia Puig-Asensio; Jesus Fortun; Mario Fernandez-Ruiz; Paloma Merino; Juan Emilio Losa; Ana Loza; Rosa Ana Rivas; Emilio Bouza
• Keywords: Male; 0301 basic medicine; Antifungal Agents; Science; Q; R; Candidemia; Middle Aged; 3. Good health; Ophthalmoscopy; 03 medical and health sciences; Spain; Medicine; Humans; Female; Prospective Studies; Research Article; Aged

The purpose of this study was to determine among patients with candidemia the real rate of ophthalmoscopy and the impact of performing ocular assessment on the outcome of the disease. We performed a post hoc analysis of a prospective, multicenter, population-based candidemia surveillance program implemented in Spain during 2010-2011 (CANDIPOP). Ophthalmoscopy was performed in only 168 of the 365 patients with candidemia (46%). Ocular lesions related to candidemia were found in only 13/168 patients (7.7%), of whom 1 reported ocular symptoms (incidence of symptomatic disease in the whole population, 0.27% [1/365]). Ophthalmological findings led to a change in antifungal therapy in only 5.9% of cases (10/168), and performance of the test was not related to a better outcome. Ocular candidiasis was not associated with a worse outcome and progressed favorably in all but 1 evaluable patient, who did not experience vision loss. The low frequency of ophthalmoscopy and ocular involvement and the asymptomatic nature of ocular candidiasis, with a favorable outcome in almost all cases, lead us to reconsider the need for systematic ophthalmoscopy in all candidemic patients.